Biohaven Ltd.
BHVN
$30.40
-$0.57-1.84%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 9.23% | 8.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.48% | -46.62% | |||
| Operating Income | -0.48% | 46.62% | |||
| Income Before Tax | -16.48% | 49.82% | |||
| Income Tax Expenses | 181.36% | -133.33% | |||
| Earnings from Continuing Operations | -16.56% | 49.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.56% | 49.87% | |||
| EBIT | -0.48% | 46.62% | |||
| EBITDA | -0.22% | 46.91% | |||
| EPS Basic | -8.85% | 53.38% | |||
| Normalized Basic EPS | -2.48% | 52.45% | |||
| EPS Diluted | -8.85% | 53.38% | |||
| Normalized Diluted EPS | -2.48% | 52.45% | |||
| Average Basic Shares Outstanding | 7.08% | 7.53% | |||
| Average Diluted Shares Outstanding | 7.08% | 7.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
